
						
							
						
						
							<!--
							google_ad_client = "pub-5806585833518451";
							/* 300x250, created 6/2/09 - iposol_ipo_detail_top */
							google_ad_slot = "4379562531";
							google_ad_width = 300;
							google_ad_height = 250;
									-->
							
							
							
						

						Healthcare Global Enterprises Ltd (HCG) is Bangalore India based provider of speciality healthcare in India focused on cancer and fertility. HCG operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed. HCG also operates fertility centres under the 'Milann' brand.As of December 31, 2015, HCG network consisted of 14 comprehensive cancer centres, including  centre of excellence in Bengaluru, three freestanding diagnostic centres and one day care chemotherapy centre across India.HCG acquired 50.10% equity in BACC Healthcare in 2013 which operates fertility centres under the Milann brand, through itself and its wholly-owned subsidiary, DKR Healthcare. HCG now operate four Milann fertility centres in Bengaluru. BACC Healthcare is led by a team of qualified and experienced fertility specialists. Its founder, Dr. Kamini Rao has a successful track record of over 25 years of providing fertility treatments. Milann fertility centres provide comprehensive reproductive medicine services, including assisted reproduction, gynaecological endoscopy and fertility preservation; and follow a multidisciplinary and technology-focused approach to diagnosis and treatment.Under Triesta brand, HCG provide clinical reference laboratory services in India with a specialisation in oncology, including molecular diagnostic services and genomic testing. Triesta central reference laboratory is located in centre of excellence in Bengaluru.Strengths of the Company:1. Largest provider of cancer care in India with a proven track record2. High quality cancer care provided at a competitive price3. Entry into high potential fertility business4. Strong management team with successful track record5. Highly skilled specialist physicians6. 'hub and spoke'  business model and partnership arrangements

						
						
							
						
						

						Company Promoters:Dr. BS Ajai Kumar, Dr. KS Gopinath, Dr. Ganesh Nayak, Dr. M Gopichand and Dr. BS Ramesh are the Promoters of the Company.

						Company Financials:



Particulars

For the year/period ended (in Rs. Million)


 
31-Mar-15
31-Mar-14
31-Mar-13
31-Mar-12
31-Mar-11


Total Liabilities
6,895.42
6,138.21
6,436.40
4,362.63
3,203.63


Total Assets
6,895.42
6,138.21
6,436.40
4,362.63
3,203.63


Total Revenue
4,244.41
3,525.94
2,939.52
2,051.67
1,601.43


Profit After Tax (PAT)
(23.66)
(394.98)
(71.58)
(40.02)
34.40





						
							<!--
								google_ad_client = "pub-5806585833518451";
								/* 300x250, created 9/3/09 - IPO Detail Center */
								google_ad_slot = "7910498455";
								google_ad_width = 300;
								google_ad_height = 250;
								-->
							
							
							
						

						Objects of the Issue:The Offer comprises of Fresh Issue and the Offer for Sale.Offer for SaleCompany will not receive any proceeds from the Offer for Sale.Fresh IssueCompany proposes to utilise the Net Proceeds towards funding the following objects:1. Purchase of medical equipment;2. Investment in IT software, services and hardware;3. Pre-payment of debt; and4. General corporate purposes.

						Issue Detail:
						Â Â Â»Â»Â Â Issue Open: Mar 16, 2016 - Mar 18, 2016
							Â Â Â»Â»Â Â Issue Type: Book Built Issue IPO
							Â Â Â»Â»Â Â Issue Size: 16,390,000 Equity Shares of Rs 10 aggregating up to Rs 357.30 Cr
							
							
							Â Â Â»Â»Â Â Face Value: Rs 10 Per Equity Share
							Â Â Â»Â»Â Â Issue Price: Rs. 205 - Rs. 218 Per Equity Share
							Â Â Â»Â»Â Â Market Lot: 65 Shares
							Â Â Â»Â»Â Â Minimum Order Quantity: 65 Shares
							Â Â Â»Â»Â Â Listing At: BSE, NSE
						

						


						
						Healthcare Global IPO Reviews:
						
							
							Healthcare Global Enterprises Ltd IPO review by Dilip Davda
							
						
						


						
							
						

						
							Issue Subscription Detail / Current Bidding StatusNumber of Times Issue is Subscribed (BSE + NSE)As on Date & TimeQIBNIIRIITotalShares Offered / Reserved8,940,0004,470,0002,980,00016,390,000Day 1 - Mar 16, 2016 17:00 IST0.34000.00050.11290.2079Day 2 - Mar 17, 2016 17:00 IST0.75000.27000.31000.5400Day 3 - Mar 18, 2016 13:00 IST2.36000.43000.83001.5600
						
					
